Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

H<sub>2</sub>S-mediated protein S-sulfhydration: a novel regulatory module in lipid metabolism.

Frontiers in cell and developmental biology·2026
Same author

Tension-band high-strength suture combined with absorbable screws with cortical penetration for treating Mayo type IIA olecranon fractures: finite element analysis, biomechanical testing, and clinical study.

Frontiers in bioengineering and biotechnology·2026
Same author

Targeting P2X receptor signaling for chronic visceral pain and beyond.

Neuropharmacology·2026
Same author

Therapeutic Effects of Shengdu Pingmu Formula on Loperamide-Induced Constipation in Rats via PI3K/AKT Signaling and Gut Microbiota Regulation.

Journal of visualized experiments : JoVE·2026
Same author

Low-temperature topotactic conversion growth of porous CoFe<sub>2</sub>O<sub>4</sub> nanocubes for an advanced oxygen evolution reaction.

Chemical communications (Cambridge, England)·2026
Same author

ASIC1a promotes alveolar epithelial apoptosis and acute lung injury through repression of the LncRNA00178/miR-466b-3p/Gucy1b1 ceRNA network.

International immunopharmacology·2026

相关实验视频

Updated: Sep 8, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.7K

转录组和代谢组的整合以揭示crizotinib诱导的小鼠肝损伤

Haoyang Chen1, Huihui Liu1, Jingyao Wei1

  • 1Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China; Henan Key Laboratory of Precision Clinical Pharmacy, Zhengzhou, P. R. China.

European journal of pharmacology
|September 6, 2025
PubMed
概括
此摘要是机器生成的。

用于治疗肺癌的克里佐替尼可通过诱导细胞死亡的一种类型 - - 铁死来引起肝损伤. 这项研究揭示了涉及胆固醇和铁代谢的分子机制,

关键词:
克里佐替尼铁症肝毒性代谢学甲基化转录组学

更多相关视频

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.0K

相关实验视频

Last Updated: Sep 8, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.7K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.0K

科学领域:

  • 肝病学
  • 癌症学
  • 毒理学

背景情况:

  • 药物诱导的肝损伤 (DILI) 是急性肝衰竭的一个重要原因.
  • 克里佐替尼是非小细胞肺癌 (NSCLC) 具有特定基因突变 (c- MET,ALK,ROS1) 的重要治疗方法.
  • 目前尚不完全了解克里佐替尼引起的肝毒性.

研究的目的:

  • 为了阐明由crizotinib引起的肝损伤的分子机制.
  • 调查铁症在克里佐替尼诱导的肝毒性中的作用.
  • 确定参与这种药物不良反应的关键代谢途径.

主要方法:

  • 在小鼠模型中进行综合转录和代谢组分析.
  • 连续两天使用crizotinib (500 mg/ kg).
  • 评估血中氨基酶水平,肝脂过氧化和细胞死亡标志物.

主要成果:

  • 在小鼠中,克里佐替尼的使用导致了转氨酶水平升高,肝脂过氧化增加和细胞死亡.
  • 多组数据表明,克里佐替尼会诱导铁.
  • 主要受影响的途径包括胆固醇代谢,谷代谢,氧化酸化和铁离子运输.
  • RNA甲基化的变化可能会导致crizotinib诱导的铁.

结论:

  • 铁是克里佐替尼引起的肝损伤的一个关键机制.
  • 这项研究提供了关于crizotinib不良反应机制的新见解.
  • 了解这些途径可以为减轻crizotinib肝毒性的策略提供信息.